Senator Markwayne Mullin (R-Oklahoma) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 18th, the Senator disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on August 1st.
UnitedHealth Group Trading Up 1.6%
Shares of NYSE UNH opened at $308.84 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a market cap of $279.71 billion, a price-to-earnings ratio of 13.38, a P/E/G ratio of 1.96 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $289.03 and a 200-day simple moving average of $394.17.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm posted $6.80 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on UNH shares. Bank of America upped their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday. Truist Financial reduced their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. TD Securities reissued a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Morgan Stanley dropped their target price on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Finally, Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $367.71.
Get Our Latest Research Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.28% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. N.E.W. Advisory Services LLC lifted its holdings in shares of UnitedHealth Group by 168.8% in the second quarter. N.E.W. Advisory Services LLC now owns 1,398 shares of the healthcare conglomerate's stock valued at $436,000 after purchasing an additional 878 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of UnitedHealth Group by 30.9% in the second quarter. Geneos Wealth Management Inc. now owns 10,825 shares of the healthcare conglomerate's stock valued at $3,377,000 after purchasing an additional 2,553 shares in the last quarter. V2 Financial group LLC lifted its holdings in shares of UnitedHealth Group by 1,395.7% in the second quarter. V2 Financial group LLC now owns 8,645 shares of the healthcare conglomerate's stock valued at $2,697,000 after purchasing an additional 8,067 shares in the last quarter. Wellington Capital Management Inc. bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $342,000. Finally, Rexford Capital Inc. bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $465,000. 87.86% of the stock is currently owned by institutional investors.
About Senator Mullin
Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father's plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.